According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -โน59.99. In 2022 the company made an earnings per share (EPS) of -โน65.99 a decrease over its 2021 EPS that were of โน151.69.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน57.46 | -12.92% |
2022 | -โน65.99 | -143.5% |
2021 | โน151.69 | -226.43% |
2020 | -โน119.98 | -11.39% |
2019 | -โน135.41 | -25.47% |
2018 | -โน181.68 | -23.94% |
2017 | -โน238.86 | 143.74% |
2016 | -โน98.00 |